Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Apremilast showed mixed results for treating severe alopecia areata.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Inclisiran is effective at lowering cholesterol.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

New drug uses show promise but need more research.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Certain cancer drugs can cause skin issues like rashes and itching.

Blocking certain brain processes reduces mating behavior in female rats.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.